Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CHFS Nuwellis	$0.86 -6.0%	$4.79	$4.86 ▼ $37.50	$5.19M	1.55	467,323 shs	93,045 shs
ECOR electroCore	$5.08 +3.7%	$5.93	$4.47 ▼ $19.49	$37.70M	0.92	94,639 shs	68,392 shs
SLNO Soleno Therapeutics	$73.24 -3.1%	$71.51	$36.93 ▼ $80.99	$3.69B	-2.67	755,661 shs	1.22 million shs
VANI Vivani Medical	$1.24 +3.4%	$1.06	$0.91 ▼ $2.09	$74.65M	2.81	161,277 shs	139,615 shs

Free Today: Your Guide to Smarter Options Trades

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CHFS Nuwellis	-6.01%	-7.33%	-13.13%	-31.20%	+203.03%
ECOR electroCore	0.00%	+2.21%	-32.89%	-66.62%	-25.29%
SLNO Soleno Therapeutics	0.00%	-4.75%	-2.37%	+50.02%	+70.76%
VANI Vivani Medical	0.00%	+9.76%	+19.26%	+11.74%	-24.37%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CHFS Nuwellis	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ECOR electroCore	2.6894 of 5 stars	3.5	2.0	0.0	0.0	3.1	2.5	0.6
SLNO Soleno Therapeutics	4.8325 of 5 stars	4.6	3.0	0.0	4.6	3.5	3.3	0.6
VANI Vivani Medical	3.2571 of 5 stars	3.5	5.0	0.0	0.0	2.7	3.3	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CHFS Nuwellis	0.00	N/A	N/A	N/A
ECOR electroCore	3.00	Buy	$25.50	401.97% Upside
SLNO Soleno Therapeutics	3.11	Buy	$106.78	45.79% Upside
VANI Vivani Medical	3.00	Buy	$4.00	222.50% Upside

Current Analyst Ratings Breakdown

Latest CHFS, SLNO, ECOR, and VANI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/19/2025	VANI Vivani Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$4.00 ➝ $4.00
5/8/2025	SLNO Soleno Therapeutics	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$81.00 ➝ $97.00
5/8/2025	SLNO Soleno Therapeutics	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$102.00 ➝ $105.00
4/24/2025	SLNO Soleno Therapeutics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$93.00 ➝ $145.00
4/16/2025	VANI Vivani Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$4.00 ➝ $4.00
4/15/2025	SLNO Soleno Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$100.00 ➝ $100.00
4/4/2025	VANI Vivani Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$4.00 ➝ $4.00
3/31/2025	SLNO Soleno Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$70.00 ➝ $100.00
3/28/2025	SLNO Soleno Therapeutics	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$70.00 ➝ $81.00
3/28/2025	SLNO Soleno Therapeutics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$74.00 ➝ $108.00
3/27/2025	SLNO Soleno Therapeutics	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$105.00

(Data available from 6/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CHFS Nuwellis	$5.51M	0.94	N/A	N/A	$12.79 per share	0.07
ECOR electroCore	$26.46M	1.42	N/A	N/A	$1.24 per share	4.10
SLNO Soleno Therapeutics	N/A	N/A	N/A	N/A	$5.16 per share	N/A
VANI Vivani Medical	N/A	N/A	N/A	N/A	$0.41 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CHFS Nuwellis	-$18.11M	-$279.28	N/A	N/A	N/A	-254.26%	-173.61%	-131.01%	N/A
ECOR electroCore	-$18.83M	-$1.56	N/A	N/A	N/A	-54.40%	-154.45%	-69.16%	8/6/2025 (Estimated)
SLNO Soleno Therapeutics	-$38.99M	-$4.62	N/A	N/A	N/A	N/A	-61.99%	-55.21%	8/6/2025 (Estimated)
VANI Vivani Medical	-$25.65M	-$0.43	N/A	N/A	N/A	N/A	-102.42%	-49.21%	8/12/2025 (Estimated)

Latest CHFS, SLNO, ECOR, and VANI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/13/2025	Q1 2025	VANI Vivani Medical	-$0.10	-$0.11	-$0.01	-$0.11	N/A	N/A
5/7/2025	Q1 2025	ECOR electroCore	-$0.56	-$0.47	+$0.09	-$0.47	$6.93 million	$6.72 million
5/7/2025	Q1 2025	SLNO Soleno Therapeutics	-$1.14	-$0.95	+$0.19	-$0.95	N/A	N/A
3/31/2025	Q4 2024	VANI Vivani Medical	-$0.10	-$0.11	-$0.01	-$0.11	N/A	N/A
3/5/2025	Q4 2024	SLNO Soleno Therapeutics	-$0.86	-$1.27	-$0.41	-$1.27	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CHFS Nuwellis	N/A	N/A	N/A	N/A	N/A
ECOR electroCore	N/A	N/A	N/A	N/A	N/A
SLNO Soleno Therapeutics	N/A	N/A	N/A	N/A	N/A
VANI Vivani Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CHFS Nuwellis	N/A	6.87	5.97
ECOR electroCore	N/A	2.12	1.87
SLNO Soleno Therapeutics	N/A	17.26	17.26
VANI Vivani Medical	N/A	3.41	3.41

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CHFS Nuwellis	65.06%
ECOR electroCore	26.74%
SLNO Soleno Therapeutics	97.42%
VANI Vivani Medical	6.78%

Insider Ownership

Company	Insider Ownership
CHFS Nuwellis	0.60%
ECOR electroCore	19.70%
SLNO Soleno Therapeutics	12.30%
VANI Vivani Medical	46.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CHFS Nuwellis	66	6.04 million	N/A	Not Optionable
ECOR electroCore	50	7.42 million	5.35 million	Not Optionable
SLNO Soleno Therapeutics	30	50.39 million	37.81 million	Optionable
VANI Vivani Medical	20	59.24 million	32.99 million	Optionable

CHFS, SLNO, ECOR, and VANI Headlines

Recent News About These Companies

Companies To Watch: Vivani Medical

May 30 at 6:03 PM | lifescienceleader.com

Vivani files with SEC to spin off neurostim business, focus on drug delivery implants

May 29 at 2:36 PM | massdevice.com

Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders

May 29 at 9:33 AM | finance.yahoo.com

HC Wainwright Estimates Vivani Medical Q1 Earnings

May 24, 2025 | marketbeat.com

HC Wainwright Weighs in on Vivani Medical Q1 Earnings

May 23, 2025 | americanbankingnews.com

Vivani Medical (NASDAQ:VANI) Receives Buy Rating from HC Wainwright

May 21, 2025 | marketbeat.com

Vivani Medical Reports Q1 2025 Results and Strategic Updates

May 20, 2025 | tipranks.com

Vivani Medical, Inc.: Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

May 15, 2025 | finanznachrichten.de

Vivani Medical, Inc. Reports Successful Initial Data from LIBERATE-1™ Study and Secures $3M in Equity Financing

May 13, 2025 | quiverquant.com

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

May 13, 2025 | globenewswire.com

Vivani Medical CEO to Present on Innovative Drug Delivery Solutions at AAPS Virtual Workshop

May 9, 2025 | nasdaq.com

Vivani Medical (VANI) Projected to Post Earnings on Monday

May 7, 2025 | marketbeat.com

Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop

May 7, 2025 | globenewswire.com

Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company

April 16, 2025 | finance.yahoo.com

Vivani Medical, Okava expand collaboration to develop OKV-119 for dogs

April 16, 2025 | markets.businessinsider.com

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

April 15, 2025 | globenewswire.com

Gregg Williams Purchases 18,529 Shares of Vivani Medical, Inc. (NASDAQ:VANI) Stock

April 12, 2025 | insidertrades.com

Vivani Medical, Inc. (NASDAQ:VANI) Director Purchases $33,660.00 in Stock

April 9, 2025 | insidertrades.com

Weight loss implants to increase compliance and cut admin burden for patients

April 3, 2025 | finance.yahoo.com

Vivani Medical Reports 2024 Financial Results and Business Progress

April 1, 2025 | tipranks.com

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

March 31, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
By Thomas Hughes | May 18, 2025
View Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith?
By Jeffrey Neal Johnson | May 22, 2025
View Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith?
Symbotic Gets Big Earnings Lift: Is the Stock Investable Again?
By Leo Miller | May 16, 2025
View Symbotic Gets Big Earnings Lift: Is the Stock Investable Again?
Gold’s Record Run in 2025: Here Are 3 Ways to Ride the Surge
By Ryan Hasson | May 7, 2025
View Gold’s Record Run in 2025: Here Are 3 Ways to Ride the Surge
e.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal
By Leo Miller | May 30, 2025
View e.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal

CHFS, SLNO, ECOR, and VANI Company Descriptions

Nuwellis NASDAQ:CHFS

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

electroCore NASDAQ:ECOR

$5.08 +0.18 (+3.67%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$4.97 -0.11 (-2.07%)

As of 05/30/2025 06:36 PM Eastern

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Soleno Therapeutics NASDAQ:SLNO

$73.24 -2.38 (-3.15%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$73.31 +0.07 (+0.09%)

As of 05/30/2025 04:44 PM Eastern

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Vivani Medical NASDAQ:VANI

$1.24 +0.04 (+3.36%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$1.24 -0.01 (-0.43%)

As of 05/30/2025 06:44 PM Eastern

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time